نتایج جستجو برای: allogenic transplantation
تعداد نتایج: 143718 فیلتر نتایج به سال:
BACKGROUND Monocytes are critical in innate immunity and transplantation. Three monocyte subsets exist, CD14(++)CD16(-), CD14(++)CD16(+) and CD14(+)CD16(++) monocytes; cell counts of CD14(++)CD16(+) and CD14(+)CD16(++) monocytes are increased in pre-transplant chronic kidney disease. Interestingly, the effect of immunosuppressants on monocyte heterogeneity has not been well studied. METHODS T...
nineteen patterns with cml have been transplanted in our bone marrow transplantation (bmt) section since 1991, the mean age of these patients was 26.05 (sd = 9.35). our conditioning regimen for these patients was cyclophosphamide 60mglkg for 2 days and busulfan 4mglkg for 4 consecutive days. eleven patients are still alive arid eight patients died during follow-up ranging from 6 months to 5 yea...
There is wide variation in the management of coagulation and blood transfusion practice in liver transplantation. The use of blood products intraoperatively is declining and transfusion free transplantations take place ever more frequently. Allogenic blood products have been shown to increase morbidity and mortality. Primary haemostasis, coagulation and fibrinolysis are altered by liver disease...
Allogenic bone marrow transplantation (BMT) is a curative therapy for malignant and nonmalignant lymphohematopoietic diseases and other disorders. However, the development of secondary malignancies is an important complication among transplantation survivors. Patients who have undergone BMT have a 2to 8-fold higher risk of developing these cancers than the general population. After BMT, the mos...
Renal ischemia-reperfusion contributes to reduced renal allograft survival. The peptide Bβ(15-42), a breakdown product of fibrin, attenuates inflammation induced by ischemia-reperfusion in the heart by competitively blocking the binding of leukocytes to endothelial VE-cadherin, but whether it could improve outcomes in renal transplantation is unknown. Here, we tested the ability of Bβ(15-42) to...
Gastroenterology Medicine & Research Gastric Post-Transplant Lymphoproliferative Disorder after Allogenic Stem Cell Transplantation Legarda M1, Garcia-Alberdi E2, Lopez-Almaraz R3, Berastegui M4, Irastorza I1,5, Vitoria JC1,5 and Astigarraga I3,5* 1Pediatric Unit, Department of Pediatrics, Cruces University Hospital, Biocruces Bizkaia Health Institute, Spain 2Department Histopathology, 3Pediatr...
Background: Chronic graft versus host disease (ch.GVHD) is the most frequent late complication after allogenic stem-cell transplantation. Systemic immunosuppressive agents are usually required to control the disease. Psoralen plus UVA (PUVA) has been used for the treatment of ch.GVHD with variable beneficial effects. The objective of this study was to assess the efficacy and safety of a r...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید